1. SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI‐CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL. (12th June 2019) Authors: Verner, E.K.; Johnston, A.J.; Pati, N.; Hawkes, E.; Lee, H.; Cochrane, T.; Cheah, C.Y.; Filshie, R.; Purtill, D.; Enjeti, A.K.; Brown, C.; Murphy, N.; Curnow, J.; Cake, S.; Carlson, J.; Butcher, B.E.; Trotman, J. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The secondary use and linking of health administrative and clinical trial data in cancer: attitudes towards data reuse in Australia. (April 2021) Authors: Hutchings, E.; Butcher, B.E.; Butow, P.; Boyle, F.M. Journal: Breast Issue: Volume 56(2021)Supplement 1 Page Start: S84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗